Skip to main content

GLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD Complications

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 17, 2025.

via HealthDay

THURSDAY, July 17, 2025 -- For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal reflux disease (GERD) and its complications compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors, according to a study published online July 15 in the Annals of Internal Medicine.

Yunha Noh, Pharm.D., Ph.D., from Chonnam National University in South Korea, and colleagues conducted an active comparator new-user cohort study to estimate the effect of GLP-1 RAs versus SGLT-2 inhibitors on the risk for GERD and its complications among patients with type 2 diabetes. Adults initiating GLP-1 RAs or SGLT-2 inhibitors between Jan. 1, 2013, and Dec. 31, 2021, were followed until March 31, 2022; data were included for 24,708 new users of GLP-1 RAs and 89,096 new users of SGLT-2 inhibitors.

The researchers found that the risk ratios were 1.27 and 1.55 for GERD and its complications, respectively, during a median follow-up of 3.0 years among GLP-1 RA users versus SGLT-2 inhibitor users, with a risk difference of 0.7 per 100 patients and 0.8 per 1,000 patients, respectively.

"Although our findings need to be corroborated in other studies, clinicians and patients should be aware of a possible adverse effect of GLP-1 RAs on GERD," the authors write.

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Higher Intake of Total Potatoes Linked to Type 2 Diabetes Risk

THURSDAY, Aug. 7, 2025 -- A higher intake of total potatoes, especially French fries, is associated with an increased risk for type 2 diabetes (T2D), according to a study...

Hearing Loss Linked to Lower Odds of Employment, Lower Income

THURSDAY, Aug. 7, 2025 -- Hearing loss is associated with a reduced likelihood of employment and with lower income among young adults, according to a study published online Aug. 1...

Study IDs Barriers to GLP-1 Receptor Agonist Use in Adolescents, Young Adults

THURSDAY, Aug. 7, 2025 -- A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.